Short Read Sequencing Market Research Report By Application (Clinical diagnostics, Agrigenomics, Oncology, Genomics Research, Molecular Biology), By Technology (Illumina sequencing, Ion Torrent sequencing, SOLiD sequencing, SMRT sequencing), By End Use (Academic research institutes, Pharmaceutical companies, Biotechnology companies, Hospitals and clinics), By Product Type (Sequencing kits, Sequencing services, Sequencing instruments) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2

Global Short Read Sequencing Market Overview

As per MRFR analysis, the Short Read Sequencing Market Size was estimated at 7.07 (USD Billion) in 2023.
The Short Read Sequencing Market Industry is expected to grow from 7.71(USD Billion) in 2024 to 20 (USD Billion) by 2035. The Short Read Sequencing Market CAGR (growth rate) is expected to be around 9.05% during the forecast period (2025 - 2035).

Key Short Read Sequencing Market Trends Highlighted

The Short Read Sequencing Market is growing quickly because genomic technologies are becoming better and more uses are being found in personalized medicine, cancer research, and infectious disease research. The falling cost of sequencing technologies is a major factor driving the market. This makes them easier for research institutes and healthcare providers to acquire. Also, the desire for precision medicine is speeding up the use of short-read sequencing since it lets researchers execute genome-wide investigations faster and more accurately. There are several possibilities to look into, such as using artificial intelligence and machine learning in data analysis. This might make sequencing findings easier to understand and more useful, which could lead to new ways to improve clinical diagnosis and treatment plans.

 Recent developments in the worldwide market show that there is a rise in partnerships between the public and commercial sectors to improve sequencing technology and its uses. Many governments are working to promote genomics research and make it easier for institutions to share more data. This is leading to greater innovation and faster results in genomic investigations. 

The development of genomic data creation has also led to a rise in demand for sequencers that can handle massive amounts of data. Also, the emphasis on non-invasive diagnostic procedures is making people increasingly interested in liquid biopsies, which use short-read sequencing to find changes in the DNA of circulating tumors.

 Overall, these new developments will help the Global short-read sequencing Market thrive. Researchers will keep putting money into it, and it will keep growing as they look for new ways to study genetics.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Short Read Sequencing Market Drivers

Increasing Demand for Personalized Medicine

The Short Read Sequencing Market Industry is significantly driven by the rising demand for personalized medicine, which tailors treatment based on individual genetic profiles. A report from the National Institutes of Health indicates a surge in the adoption of genomic information in clinical settings, with over 80% of medical institutions integrating genetic data into patient management plans. Organizations such as Illumina have spearheaded initiatives to transform genomic data into actionable healthcare insights, leading to breakthroughs in treating complex diseases like cancer and rare genetic disorders.

With the projected demand for personalized treatments expected to rise by upwards of 15% annually, the evolution of tailored medication is creating robust growth potential for the Short Read Sequencing Market, allowing for enhanced patient outcomes and customized therapies.

Advancements in Sequencing Technologies

The rapid advancements in sequencing technologies, particularly High Throughput Sequencing, are propelling the Short Read Sequencing Market Industry forward. The FDA reported a remarkable improvement in sequencing accuracy and throughput, which has facilitated the exploration of genomic sequences at an unprecedented scale. Companies like Thermo Fisher Scientific are heavily investing in Research and Development to enhance sequencing platforms, increasing output levels by approximately 50% over the last five years.

Such advancements not only minimize the cost per base of sequencing but also accelerate research timelines, capturing significant interest from both academia and biotechnology firms, further catalyzing market growth.

Rising Incidence of Genetic Disorders

The increasing incidence of genetic disorders worldwide is a major driver for the Short Read Sequencing Market Industry. According to the World Health Organization, genetic disorders affect approximately 10% of the global population, with about 300 million people suffering from rare diseases. This alarming statistic underlines the urgent need for effective diagnostics, where short-read sequencing techniques serve as a crucial tool in understanding and diagnosing these conditions.

Organizations such as the Global Genes Project are raising awareness and promoting research in this field, paving the way for innovative genome mapping techniques. Consequently, the demand for accurate and efficient sequencing solutions is projected to grow, fundamentally supporting the market's expansion.

Short Read Sequencing Market Segment Insights

Short Read Sequencing Market Application Insights

The Short Read Sequencing Market under the Application segment showcases a robust growth trajectory with revenue expected to reach 7.71 USD Billion by 2024 and 20.0 USD Billion by 2035. The market is significantly driven by various key applications including Clinical diagnostics, Agrigenomics, Oncology, Genomics Research, and Molecular Biology, each playing a crucial role in enhancing healthcare and scientific research worldwide. Among these applications, Clinical diagnostics emerges as a major driving force, holding a valuation of 2.5 USD Billion in 2024 and growing to 6.4 USD Billion by 2035, underscoring its pivotal role in patient care and disease management.

Agrigenomics also commands attention with projections of 1.7 USD Billion in 2024 rising to 4.2 USD Billion by 2035, reflecting the increasing demand for genetic analysis in agriculture to improve crop yields and resistance. Oncology, valued at 1.8 USD Billion in 2024 and expected to reach 4.6 USD Billion by 2035, is particularly vital as it offers techniques for the early detection and targeted treatment of various cancers, thus significantly impacting patient outcomes. Moreover, Genomics Research is projected to grow from 1.3 USD Billion in 2024 to 3.3 USD Billion by 2035, highlighting its importance in unlocking genetic information that could lead to breakthroughs in personalized medicine.

Lastly, Molecular Biology, albeit with a smaller valuation of 0.41 USD Billion in 2024, is anticipated to increase to 1.5 USD Billion by 2035, emphasizing its foundational role in understanding biological processes and advancements in biotechnology. The collective contributions of these applications illuminate the market dynamics, as advancements in sequencing technologies drive innovation and adoption across multiple domains, benefiting areas such as diagnostics, therapeutic development, and agricultural enhancements. With substantial Short Read Sequencing Market statistics reflecting the accelerating demand for accurate genetic analysis and personalized solutions, the industry is set for significant growth, reinforced by both technological advancements and the increasing emphasis on genomic-centric approaches in various fields.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Short Read Sequencing Market Technology Insights

The Short Read Sequencing Market, focusing on the Technology segment, has shown significant growth trends, underpinned by innovations across various sequencing technologies. As per recent data, the market is expected to achieve a valuation of 7.71 USD Billion by 2024, highlighting its robust expansion. This segment includes prominent technologies like Illumina sequencing, Ion Torrent sequencing, SOLiD sequencing, and SMRT sequencing. Illumina sequencing dominates the market due to its widespread adoption in clinical applications and Research and Development, thanks to its high throughput and accuracy.

Ion Torrent sequencing is recognized for its rapid and cost-effective solutions, making it valuable in both research and diagnostic settings. Meanwhile, SOLiD sequencing, although less prevalent than others, is noted for its unique sequencing approach that ensures high fidelity, particularly in targeted resequencing studies. Finally, SMRT sequencing stands out for its capability of sequencing long reads, thus providing a fuller genomic picture. The Short Read Sequencing Market is influenced by rising demand for genomic data, advancements in sequencing technology, and ongoing initiatives in personalized medicine, all contributing to its projected growth trajectory.

Short Read Sequencing Market End Use Insights

The Short Read Sequencing Market, expected to achieve a valuation of 7.71 USD Billion in 2024, is witnessing significant growth driven by its application across various end-use sectors. Academic research institutes are essential as they leverage short read sequencing for groundbreaking discoveries in genomics and molecular biology, providing a foundation for further academic advancements. Pharmaceutical companies utilize this technology for drug development and personalized medicine, making it a pivotal component of R&D efforts. Biotechnology companies are heavily invested in this market as they employ sequencing to innovate new therapies and products, showcasing its importance in bioproduct development.

Meanwhile, hospitals and clinics incorporate short read sequencing for diagnostics and patient management, highlighting its practical implications in healthcare. The growing demand for precise genetic analysis and the surge in genomic studies and initiatives at the global level have spurred market growth. Overall, the Short Read Sequencing Market segmentation reflects a diversified range of applications, positioning it as a crucial tool in enhancing research, drug development, and clinical practices worldwide. Market trends suggest increasing investment in these end-use segments, creating vast opportunities for advancements in genomics and personalized healthcare solutions across the globe.

Short Read Sequencing Market Product Type Insights

The Short Read Sequencing Market is expected to experience substantial growth, with a projected valuation of 7.71 USD Billion in 2024. This market, driven by advancements in genomics and biotechnology, is witnessing an increasing demand for various product types essential for sequencing processes. Among these, sequencing kits, sequencing services, and sequencing instruments are critical components contributing to the market's expansion. Sequencing kits are fundamental, providing researchers with the necessary tools to conduct genetic analyses, while sequencing services streamline the process for organizations lacking in-house capabilities, demonstrating significant reliance on outsourced solutions.

Additionally, sequencing instruments are pivotal in enhancing accuracy and efficiency in sequencing operations, ensuring high-quality results that are essential in fields like clinical diagnostics and personalized medicine. As the Short Read Sequencing Market continues to evolve, navigating through developments, growth drivers, and challenges, the synergy between these product types remains significant for facilitating innovation and improving health outcomes globally. Market growth is aligned with the increasing applications of sequencing technology, from basic research to clinical diagnostics, benefiting from supportive government initiatives promoting genomic research and healthcare advancements globally.

Short Read Sequencing Market Regional Insights

The Regional analysis of the Short Read Sequencing Market reveals significant variations in growth and valuation across various areas, with North America demonstrating a strong market presence. Valued at 3.45 USD Billion in 2024, this region is expected to reach 8.8 USD Billion by 2035, indicating a substantial contribution to the overall market. Europe holds a notable share as well, estimated at 2.25 USD Billion in 2024 and anticipated to grow to 5.7 USD Billion by 2035, driven by advanced Research and Development initiatives and strengthening healthcare infrastructures.

In contrast, South America starts at a smaller base of 0.5 USD Billion in 2024, growing to 1.2 USD Billion by 2035, reflecting emerging opportunities in biotechnological applications. Asia Pacific captures attention with a valuation of 1.8 USD Billion in 2024, climbing to 4.5 USD Billion by 2035, signalling an expanding market bolstered by rising investment in genomics and personalized medicine. The Middle East and Africa, starting at 0.71 USD Billion in 2024 and progressing to 1.8 USD Billion by 2035, represent growing sectors with increasing awareness and capabilities in genomics.

This diverse geographical spread highlights crucial market growth drivers, such as heightened demand for genomic data, advancements in sequencing technologies, and a push towards personalized healthcare solutions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Short Read Sequencing Market Key Players and Competitive Insights

The Short Read Sequencing Market has witnessed significant growth and innovation, driven by advancements in sequencing technologies and increasing applications in genomics, personalized medicine, and genetic research. This market is characterized by a competitive landscape where various players are striving to gain a substantial share through the development of cutting-edge technologies and strategic collaborations. The significant demand from academic research centers, pharmaceutical companies, and biotechnology firms has intensified competition among key stakeholders. As the market evolves, players are focusing on enhancing the efficiency and accuracy of sequencing methods, reducing costs, and improving data analysis capabilities. Emerging trends, such as the integration of artificial intelligence and machine learning in sequencing analysis, are also influencing the competitive dynamics within the market.

Applied Biosystems has carved out a significant niche in the Short Read Sequencing Market with its focus on delivering high-throughput sequencing solutions that are widely utilized in academic, clinical, and industrial applications. The company's offerings include a range of sequencing instruments, platform solutions, and comprehensive support services designed to enhance the efficiency of sequencing workflows. Applied Biosystems is known for its commitment to providing reliable and accurate results, which is pivotal for applications in genomics and personalized medicine. 

The company's strengths can be attributed to its extensive experience in the field, a robust product portfolio, and ongoing investments in research and development. Additionally, strategic mergers and acquisitions have enabled Applied Biosystems to expand its capabilities and enhance its market reach, allowing them to respond effectively to the evolving demands of the global market and solidify its position as a leader in the short read sequencing arena.

Key Companies in the Short Read Sequencing Market Include:

• Applied Biosystems


• Element Biosciences


• Thermo Fisher Scientific


• PerkinElmer


• Agilent Technologies


• BGI


• Qiagen


• Illumina


• 10x Genomics


• BioRad Laboratories

Short Read Sequencing Market Industry Developments

Recent developments in the Short Read Sequencing Market have shown significant advancements, with companies such as Illumina and Thermo Fisher Scientific pushing the boundaries through innovations in sequencing technologies. As of September 2023, Illumina's acquisition of Grail has been finalized, expanding its presence in the multi-cancer early detection space while enhancing its sequencing capabilities. 

BGI is also demonstrating growth, leveraging collaborations and partnerships to enhance their product offerings in short read sequencing. The global market is experiencing a surge in funding; for instance, Element Biosciences secured significant investment to enhance its engineering capabilities. Additionally, recent reports indicated that the market demand for short-read sequencing is expected to increase rapidly due to the expansion of applications across healthcare and environmental sectors. 

Over the past two years, various advancements in technology have decreased costs and improved accessibility, fostering further growth within this competitive landscape, and shaping the future of genomics worldwide.

Short Read Sequencing Market Segmentation Insights

Short Read Sequencing Market Application Outlook

• Clinical diagnostics


• Agrigenomics


• Oncology


• Genomics Research


• Molecular Biology

Short Read Sequencing Market Technology Outlook

• Illumina sequencing


• Ion Torrent sequencing


• SOLiD sequencing


• SMRT sequencing

Short Read Sequencing Market End Use Outlook

• Academic research institutes


• Pharmaceutical companies


• Biotechnology companies


• Hospitals and clinics

Short Read Sequencing Market Product Type Outlook

• Sequencing kits


• Sequencing services


• Sequencing instruments

Short Read Sequencing Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	7.07(USD Billion)
Market Size 2024	7.71(USD Billion)
Market Size 2035	20.0(USD Billion)
Compound Annual Growth Rate (CAGR)	9.05% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Applied Biosystems, Element Biosciences, Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, BGI, Qiagen, Illumina, 10x Genomics, BioRad Laboratories
Segments Covered	Application, Technology, End Use, Product Type, Regional
Key Market Opportunities	Increased demand for genomics research, Advancements in sequencing technologies, Growth of personalized medicine, Expansion in diagnostics applications, Rise in funding for biotech innovation
Key Market Dynamics	Technological advancements, Increasing research funding, Rising prevalence of genetic disorders, Growing demand for personalized medicine, Development of novel applications
Countries Covered	North America, Europe, APAC, South America, MEA